Composition and method for fertility therapy using nutritional supplements
Inventors
Andrews, Kelly • Grunebaum, Amos N
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-8663709-B1
Publication Date
2014-03-04
Expiration Date
Abstract
A new composition and method are described for male fertility therapy. In one alternative, the composition utilizes three nutritional supplements, Lepidium meyenii, L-carnitine, and Coenzyme Q10. When it is administered to males as fertility therapy following the recommended therapeutic regimen, enhanced sperm count, sperm quality, and sperm motility results.
Core Innovation
The invention relates to a fertility-enhancing composition for human male fertility therapy. The composition includes a sperm count enhancing dose of Lepidium meyenii, a sperm quality enhancing dose of carnitine, and a sperm motility enhancing dose of Coenzyme Q10, together with a multi-vitamin comprising Vitamin A, Vitamin C, Vitamin D3, Vitamin E, Vitamin K, thiamine, Riboflavin, Niacin, Vitamin B6, Folic Acid, Vitamin B12, Pantothenic Acid, and further includes Iodine, Magnesium, Zinc, Selenium, Copper, Manganese, and Chromium, and at least one additional nutrient selected from the group consisting of grape seed and ginseng.
The disclosed composition is formulated as a specific combination that includes defined vitamin and mineral cofactors and optionally grape seed and/or ginseng. The multi-vitamin and multi-mineral components are associated with standardized ingredient forms, including beta carotene, ascorbic acid, cholicalciferol, d-alpha tocopheryl succinate, and kelp-derived iodine, together with specified mineral salts and cofactor standards.
The disclosure also provides a male fertility treatment method in which a male human receives an effective amount of the disclosed composition to enhance fertility. The treatment is directed to increasing sperm count, sperm quality, and sperm motility, and in embodiments includes administering the composition in one to three doses per day until conception is achieved by a female partner of the male human or for at least 3 months, with optional administration of an appropriate fertility enhancing composition to the female partner for female fertility therapy.
Claims Coverage
The document includes two independent claims. The inventive structure is the combined use of Lepidium meyenii, carnitine, and Coenzyme Q10 together with a multi-vitamin/mineral blend and optional grape seed and ginseng, with further dependents specifying ingredient forms and about-specified dosage ranges, and converting the composition into a treatment method with defined dosing and continuation conditions.
Sperm count, quality, and motility enhancing combination in a multi-vitamin/mineral blend
A fertility-enhancing composition for human male fertility therapy comprising a sperm count enhancing dose of Lepidium meyenii, a sperm quality enhancing dose of carnitine, a sperm motility enhancing dose of Coenzyme Q10, a multi-vitamin comprising Vitamin A, Vitamin C, Vitamin D3, Vitamin E, Vitamin K, thiamine, Riboflavin, Niacin, Vitamin B6, Folic Acid, Vitamin B12, Pantothenic Acid, Iodine, Magnesium, Zinc, Selenium, Copper, Manganese, Chromium, and at least one additional nutrient selected from the group consisting of grape seed and ginseng.
Fertility-enhancing composition defined by about-specified amounts
A fertility-enhancing composition for male fertility therapy consisting of about 80 mg to about 8 gm of Lepidium Meyenii, about 10 mg to about 1000 mg of carnitine, about 1 mg to about 150 mg of Coenzyme Q10, about 10 mg to about 1000 mg of grape seed, about 5 mg to about 500 mg of ginseng, about 1 mg to about 150 mg Vitamin A, about 25 mg to about 2500 mg of Vitamin C, about 1 mg to about 40 mg of Vitamin D3, about 15 mg to about 1500 mg of Vitamin E, about 8 mcg to about 800 mcg of Vitamin K, about 0.2 mg to about 15 mg thiamine, about 2 mg to about 200 mg of niacin, about 0.2 mg to about 200 mg of Vitamin B6, about 50 mcg to about 5 mg of folic acid, about 2.5 mcg to about 250 mcg of Vitamin B12, about 1 mg to about 100 mg of pantothenic acid, about 1.5 mg to about 150 mg of iodine, about 20 mg to about 2000 mg of magnesium, about 10 mg to about 300 mg of zinc, about 10 mcg to about 1 mg of selenium, about 200 mcg to about 20 mg of copper, about 200 mcg to about 20 mg of manganese, and about 12 mcg to about 1.2 mg of chromium.
Overall claim coverage centers on a fertility-enhancing composition for human male fertility therapy combining Lepidium meyenii for sperm count, carnitine for sperm quality, and Coenzyme Q10 for sperm motility, together with a multi-vitamin comprising specified vitamins, plus Iodine and multiple minerals and at least one additional nutrient selected from grape seed and ginseng. The second independent claim further specifies the composition by defining about-specified dosage ranges for Lepidium meyenii, carnitine, Coenzyme Q10, grape seed, ginseng, and the listed vitamins and minerals.
Stated Advantages
Enhances male fertility by increasing sperm count, sperm quality, and sperm motility.
Documented Applications
Human male fertility therapy for oligoasthenospermia, where an example clinical study is described as showing a higher pregnancy rate and improved sperm vitality/morphology and motility in an active group versus placebo.
Interested in licensing this patent?